which lung cancer mutations have approved targeted therapies?
Published 5 years ago • 514 plays • Length 0:37Download video MP4
Download video MP3
Similar videos
-
1:10
what are lung cancer tumor mutations?
-
4:23
understanding mutations in lung cancer
-
1:18
what is the stk11 mutation?
-
30:32
2023 best of lung: targeted therapies in lung cancer
-
0:46
clinical trials and lung cancer biomarkers
-
5:03
understanding nsclc treatment when you have an egfr mutation
-
47:57
lung cancer new treatment 2023
-
1:08:25
updates on immunotherapy for lung cancer patients
-
3:30
understanding mutations and targeted therapy in lung cancer
-
5:08
genetic mutations in lung cancer - lung cancer foundation of america (lcfa)
-
15:25
targeted therapies: the future of non-small cell lung cancer (nsclc) treatment?
-
0:31
discovering hope and progress in lung cancer treatment: carla's story short
-
4:10
egfr mutations in advanced nsclc - targeted therapies in lung cancer 2023
-
4:08
targeted therapies in lung cancer
-
1:42
treating kras g12c mutations
-
5:53
targeted therapy in non-small cell lung cancer
-
1:45
strategies to target her2 in lung cancer
-
4:04
what are common lung cancer mutations?
-
2:00
testing for rare mutations in lung cancer in the us
-
0:36
advancements in lung cancer research
-
0:54
who is eligible for targeted and immune therapies?
-
1:50
lung cancer and biomarker testing: two families’ stories